CAS 2126928-92-3
:Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
7 produits concernés.
Clindamycin Palmitate Hydrochloride Sulfoxide (7-Chloro-1,6,7,8-tetradeoxy-6-[(2S,4R)-1-methyl-4-propylpyrrolidine-2-carboxamido]-1-methylsulfinyl-L-threo-α-D-galacto-octopyranose 2-palmitate hydrochloride)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C34H63ClN2O7S·HClCouleur et forme :White PowderMasse moléculaire :714.38113Clindamycin Palmitate Sulfoxide HCl
CAS :Formule :C34H63ClN2O7S·HClCouleur et forme :White To Off-White SolidMasse moléculaire :679.40 36.46Clindamycin Palmitate Sulfoxide HCl (Mixture of Diastereomers)
CAS :Formule :C34H63ClN2O7S·HClMasse moléculaire :679.40 36.46Clindamycin Palmitate Sulfoxide Hydrochloride (>90%)
CAS :Produit contrôlé<p>Applications Clindamycin Palmiitate Sulfoxide Hydrochloride, is an impurity in the synthesis of Clindamycin Palmitate Hydrochloride (C580035), a semi-synthetic antibiotic with high bioavailability. Clindamycin Palmitate is an antibacterial.<br>References Bharathi, Ch. et al.: J. Pharm. Biomed. Anal., 48, 1211 (2008); Platzer, D., et al.: J. Pharm. Biomed. Anal., 41, 84 (2006);<br></p>Formule :C34H63ClN2O7S·ClHDegré de pureté :>90%Couleur et forme :NeatMasse moléculaire :715.85Clindamycin 2-palmitate sulfoxide
CAS :<p>Clindamycin 2-palmitate sulfoxide is a semisynthetic antibiotic, which is a derivative of clindamycin. It originates from lincomycin, a natural antibiotic produced by the bacterium *Streptomyces lincolnensis*. This compound functions as a prodrug, which is converted into its active form in the body. Its mode of action involves inhibiting bacterial protein synthesis by binding to the 50S subunit of the ribosome, thereby preventing the growth and replication of susceptible bacteria.</p>Formule :C34H64Cl2N2O7SDegré de pureté :Min. 95%Masse moléculaire :715.9 g/molClindamycin Palmitate Sulfoxide Hydrochloride
CAS :Formule :C34H63ClN2O7SHClMasse moléculaire :679.40 : 36.46
